Aurinia Pharma

AUPH

15.2101.67% ( +0.250 )

Trading: Jul 29, 14:42:57 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Aurinia Pharma(AUPH) predict that the Revenue is 77.71 M (+24.4%), Beat estimate;the EBIT is 41.42 M (+89.6%), Beat estimate;the EPS is 0.25 (+56.25%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.08B24.40%

0.08B23.23%

+0.00B1.17%

EBITExceed expectations

0.04B89.60%

0.03B42.67%

+0.01B46.93%

EPSExceed expectations

0.2556.25%

0.19521.88%

+0.055034.37%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD